BRD2 and hypogonadism: Luteinizing hormone (LH) and follicle-stimulating hormone (FSH) levels were markedly elevated in the hypogonadism group, consistent with hypergonadotropic hypogonadism and impaired negative feedback regulation of the hypothalamic–pituitary–gonadal axis.